MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
Go back to MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.14 +0.21 (5.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $2.51 | |||
| Open | $3.90 | 52 Week Low | $0.41 | |||
| Day High | $4.19 | P/E | N/A | |||
| Day Low | $3.90 | EPS | $-0.64 | |||
| Volume | 11,867,915 | |||||
